TY - JOUR
T1 - Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function
AU - Liu, Kai
AU - Nilsson, Ralf
AU - Lázaro-Ibáñez, Elisa
AU - Duàn, Hanna
AU - Miliotis, Tasso
AU - Strimfors, Marie
AU - Lerche, Michael
AU - Salgado Ribeiro, Ana Rita
AU - Ulander, Johan
AU - Lindén, Daniel
AU - Salvati, Anna
AU - Sabirsh, Alan
N1 - Funding Information:
K.L. acknowledges the financial support from the AstraZeneca Postdoc program. A. Salvati. received financial support from European Research Council (Grant No.637614). The authors thank Dr. Anders Broo and Dr. Lars Tornberg for discussions related to data analysis. The authors also thank Mario Soriano (Centro Investigación Príncipe Felipe, Valencia, Spain) for the electron microscopy analysis. Dr. Sara Pereira and Dr. Lili Cui kindly contributed some additional nanoparticle formulations. Dr. Henrik Palmgren performed preliminary experiments.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/7/6
Y1 - 2023/7/6
N2 - In terms of lipid nanoparticle (LNP) engineering, the relationship between particle composition, delivery efficacy, and the composition of the biocoronas that form around LNPs, is poorly understood. To explore this we analyze naturally efficacious biocorona compositions using an unbiased screening workflow. First, LNPs are complexed with plasma samples, from individual lean or obese male rats, and then functionally evaluated in vitro. Then, a fast, automated, and miniaturized method retrieves the LNPs with intact biocoronas, and multiomics analysis of the LNP-corona complexes reveals the particle corona content arising from each individual plasma sample. We find that the most efficacious LNP-corona complexes were enriched with high-density lipoprotein (HDL) and, compared to the commonly used corona-biomarker Apolipoprotein E, corona HDL content was a superior predictor of in-vivo activity. Using technically challenging and clinically relevant lipid nanoparticles, these methods reveal a previously unreported role for HDL as a source of ApoE and, form a framework for improving LNP therapeutic efficacy by controlling corona composition.
AB - In terms of lipid nanoparticle (LNP) engineering, the relationship between particle composition, delivery efficacy, and the composition of the biocoronas that form around LNPs, is poorly understood. To explore this we analyze naturally efficacious biocorona compositions using an unbiased screening workflow. First, LNPs are complexed with plasma samples, from individual lean or obese male rats, and then functionally evaluated in vitro. Then, a fast, automated, and miniaturized method retrieves the LNPs with intact biocoronas, and multiomics analysis of the LNP-corona complexes reveals the particle corona content arising from each individual plasma sample. We find that the most efficacious LNP-corona complexes were enriched with high-density lipoprotein (HDL) and, compared to the commonly used corona-biomarker Apolipoprotein E, corona HDL content was a superior predictor of in-vivo activity. Using technically challenging and clinically relevant lipid nanoparticles, these methods reveal a previously unreported role for HDL as a source of ApoE and, form a framework for improving LNP therapeutic efficacy by controlling corona composition.
UR - http://www.scopus.com/inward/record.url?scp=85164269369&partnerID=8YFLogxK
U2 - 10.1038/s41467-023-39768-9
DO - 10.1038/s41467-023-39768-9
M3 - Article
C2 - 37414857
AN - SCOPUS:85164269369
SN - 2041-1723
VL - 14
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 4007
ER -